Neurodex Faces Review Prolongation Due To QT Submission
Priority review of the involuntary emotional expression disorder therapy is extended by 90 days to allow for sufficient consideration of newly submitted data.
Priority review of the involuntary emotional expression disorder therapy is extended by 90 days to allow for sufficient consideration of newly submitted data.